EP1504116A1 - Procede et systeme de reactifs contenant une enzyme inactivee - Google Patents

Procede et systeme de reactifs contenant une enzyme inactivee

Info

Publication number
EP1504116A1
EP1504116A1 EP03752757A EP03752757A EP1504116A1 EP 1504116 A1 EP1504116 A1 EP 1504116A1 EP 03752757 A EP03752757 A EP 03752757A EP 03752757 A EP03752757 A EP 03752757A EP 1504116 A1 EP1504116 A1 EP 1504116A1
Authority
EP
European Patent Office
Prior art keywords
coenzyme
enzyme
dehydrogenase
analyte
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03752757A
Other languages
German (de)
English (en)
Inventor
Carina Horn
Joachim Hoenes
Wolfgang-Reinhold Knappe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002121846 external-priority patent/DE10221846A1/de
Priority claimed from DE2002121840 external-priority patent/DE10221840A1/de
Priority claimed from DE2002121845 external-priority patent/DE10221845A1/de
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Publication of EP1504116A1 publication Critical patent/EP1504116A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/002—Electrode membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Definitions

  • the invention relates to a method and a reagent system for the detection of an analyte in a sample by an enzymatic reaction, comprising the use of a detection reagent which contains a coenzyme and a catalytically inactive coenzyme-binding protein.
  • the detection of analytes, for example glucose in blood, by enzymatic methods is known.
  • the analyte to be determined is mixed with a detection reagent that contains a detectable by an enzymatic reaction, e.g. reducible or oxidizable, containing coenzyme, brought into contact.
  • a detection reagent that contains a detectable by an enzymatic reaction, e.g. reducible or oxidizable, containing coenzyme, brought into contact.
  • the redox equivalents that result from the reduction or oxidation of the coenzyme can be transferred to mediators, which are then recorded electrochemically or photometrically in a further step.
  • a calibration provides a direct relationship between the measured value and the concentration of the analyte to be determined.
  • mediators on the one hand require the use of complex reaction mixtures, which lead to a low stability and a high susceptibility to interference of the detection reaction, on the other hand mediators are often required in order to be able to carry out a detection or a sufficient one To achieve detection sensitivity.
  • the object underlying the present invention was to at least partially avoid the disadvantages of the prior art described.
  • an insensitive and sensitive Methods for the detection of analytes are provided, which leads to reliable measurement results even in the absence of mediators.
  • a catalytically inactive coenzyme-binding protein is added to the other constituents of an enzymatic detection reagent.
  • the catalytically inactive protein is able to bind a coenzyme modified by reaction of the analyte and thus to improve its detectability, in particular by optical methods.
  • the invention thus relates to a method for the detection of an analyte in a sample by an enzymatic reaction, comprising the steps:
  • the invention further relates to a reagent system for the detection of an analyte in a sample, comprising: (a) a coenzyme and (b) a catalytically inactive coenzyme-binding protein.
  • the present invention enables simple qualitative or quantitative determination of analytes by an enzymatic reaction.
  • the method is suitable for the detection of any analytes that can be detected by an enzymatic reaction with the participation of a coenzyme.
  • the method according to the invention is distinguished from known methods in that the Detection reagent a catalytically inactive coenzyme-binding protein is added, whereby an improved detection sensitivity is brought about.
  • the detection reagent contains the catalytically inactive protein in a sufficient amount to enable improved sensitivity in a qualitative and / or quantitative determination of the analyte in accordance with the desired test format. Since the method according to the invention preferably detects the coenzyme modified by the enzymatic reaction, in many cases the presence of mediators or other substances which can bring about regeneration of the coenzyme is not necessary.
  • the method and the detection system allow the use of very small sample quantities, for example sample volumes ⁇ 1 ⁇ ⁇ , preferably ⁇ 0, 1 ⁇ ⁇ . If necessary, the sample can be diluted before contact with the detection reagent.
  • the method and detection system according to the invention is suitable for determining any analyte, for example parameters in biological samples, such as body fluids, such as blood, serum, plasma or urine, but also in waste water samples or food.
  • the method can be used both as a wet test, e.g. in a cuvette, or as a dry test on an appropriate reagent carrier.
  • any biological or chemical substances that can be determined by an enzymatic reaction such as enzymes or enzyme substrates, can be selected as the analyte, the reaction comprising, in particular, a redox reaction.
  • suitable analytes are, for example, glucose, lactic acid, malic acid, glycerol, alcohol, cholesterol, triglycerides, ascorbic acid, cysteine, glutathione, peptides etc.
  • the enzymatic reaction is preferably a redox reaction in which the coenzyme to be detected is reduced or oxidized.
  • an oxidoreductase is preferably used as the enzyme in the detection reagent.
  • a dehydrogenase is particularly preferably used as the enzyme, for example selected from a glucose dehydrogenase (EC1 .1 .1 .47), lactate dehydrogenase (EC1 .1 .1 .27, 1 .1 .1 .28), malate dehydrogenase ⁇ EC1 .1 .1 .37), glycerol dehydrogenase (EC1 .1 .1 .6), alcohol dehydrogenase (EC1 .1 .1 .1) or amino acid dehydrogenase, e.g. L-amino acid dehydrogenase (EC1 .4.1 .5).
  • Other suitable enzymes are oxidases, such as glucose oxidase (EC1 .1 .3.4) or cholesterol oxidase (EC1 .1 .3.6).
  • the detection reaction is preferably a reduction or oxidation and an oxidoreductase is detected as an enzyme.
  • Coenzymes in the sense of the present invention are preferably organic molecules which are covalently or non-covalently bound to an enzyme and which are changed, for example oxidized or reduced, by the reaction of the analyte.
  • Preferred examples of coenzymes are flavin, nicotine and quinone derivatives, for example flavin nucleoside derivatives such as FAD, FADH 2 , FMN, FMNH 2 , etc., nicotine nucleoside derivatives such as NAD + , NADH / FT, NADP + , NADPH / FT etc. or Ubiquinones, such as coenzyme Q, PQQ etc.
  • NADH / H + is particularly preferred as the coenzyme.
  • the change in the coenzyme by reaction with the analyte can in principle be detected in any manner. In principle, all methods known from the prior art for the detection of enzymatic reactions can be used here. Preferably however, the change in the coenzyme is detected by optical methods. Optical detection methods include, for example, the measurement of absorption, fluorescence, circular dichroism (CD), optical rotation dispersion (ORD) or refractometry. The change in the coenzyme is particularly preferably detected by measuring the fluorescence. The fluorescence measurement is highly sensitive and enables the detection of even low concentrations of the analyte in miniaturized systems.
  • the detectability is improved, in particular by optical methods.
  • the binding of the coenzyme to a catalytically inactive protein leads in particular to an improved fluorescence yield of the coenzyme.
  • the method or detection system according to the invention can comprise a liquid test, the reagent e.g. is in the form of a solution or suspension in an aqueous or non-aqueous liquid or as a powder or lyophilisate.
  • the method and detection system according to the invention preferably includes a dry test, the reagent being applied to a support.
  • the carrier can comprise, for example, a test strip comprising an absorbent and / or swellable material which is wetted by the sample liquid to be examined.
  • the catalytically inactive coenzyme-binding protein is able to bind the coenzyme formed as the product of the enzymatic detection reaction, whereby the binding of the coenzyme results in an improved detectability of the coenzyme reaction product.
  • the catalytically inactive protein is preferably an inactivated enzyme or a fragment of an inactivated enzyme which is not catalytically active but still contains a coenzyme binding site.
  • an inactivated oxidoreductase e.g. B. an inactivated dehydrogenase.
  • an inactivated NADH-binding dehydrogenase such as glucose dehydrogenase, is particularly preferred.
  • Inactivation of enzymes can be brought about by mutations in the amino acid sequence, for example deletions, insertions and / or substitutions of individual amino acids or sections of several amino acids.
  • a mutation takes place in the catalytic center of the enzyme.
  • glucose dehydrogenase can be mutagenized on the histidine residue at position 14, which is essential for the catalytic activity, for example to serine or tryptophan.
  • the enzyme can also be inactivated by chemical modifications, for example chemical modifications in the catalytic center, by which the catalytic activity is at least largely eliminated, while the ability to bind the coenzyme is retained.
  • the detection reagent is stored in a matrix, for example in an absorbent material or in a gel matrix.
  • the gel matrix preferably has a layer thickness of ⁇ 50 ⁇ m, in particular ⁇ 5 ⁇ m, and is applied to a carrier, for example an at least partially optically transparent carrier.
  • the gel matrix is preferably a polymer which is based on photopolymerizable monomers, such as acrylic monomers, for example acrylamide or / and acrylic esters, such as polyethylene glycol diacrylate, or vinyl aromatic monomers, for example 4-vinylbenzenesulfonic acid, or combinations thereof.
  • a liquid containing the reagent comprising a coenzyme, a catalytically inactive protein can be used to produce such a gel matrix or contains several photopolymerizable monomers and optionally enzyme, photoinitiator and / or non-reactive constituents, applied to an at least partially optically transparent support, for example on a plastic film, and irradiated, for example, with UV light from the back, so that the monomer polymerizes or the monomers on the carrier take place up to a predetermined layer thickness.
  • the layer thickness can be controlled by adding absorbent substances to the reagent and / or by the duration or intensity of the irradiation. Excess liquid reagent can be removed after the polymerization and used again.
  • the matrix can also be produced by conventional coating procedures, the liquid reagent being applied to a support, there using suitable methods, e.g. with a doctor blade, brought to the desired thickness and then dried or completely polymerized.
  • the catalytically inactive protein and possibly the enzyme are in a protected microenvironment. If the polymeric gel matrix is sufficiently cross-linked, the protein molecules are in an immobilized form. Low molecular weight substances or glucose or other analytes or also coenzymes can diffuse freely through the polymer network.
  • the catalytically inactive protein and optionally the enzyme can be polymerized into the matrix together with the coenzyme, or the matrix can be brought into contact with a solution of the coenzyme after the polymerization, so that it can diffuse into the matrix.
  • the coenzyme modified, for example reduced or oxidized, by the reaction is optimally protected from interferences by binding to the inactive protein and, if appropriate, additionally by incorporation into the gel matrix. Furthermore, the present invention is to be explained in more detail by the following example.
  • the essential histidine of GlucDH at position 147 was exchanged for serine by known methods.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Polymerisation Methods In General (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Laminated Bodies (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Moulding By Coating Moulds (AREA)

Abstract

L'invention concerne un procédé et un système de réactifs destinés à la détection d'un analyte dans un échantillon par l'intermédiaire d'une réaction enzymatique. Le procédé et le système de réactifs selon l'invention font intervenir un réactif de détection contenant une coenzyme et une protéine catalytiquement inactive se liant à des coenzymes.
EP03752757A 2002-05-16 2003-05-16 Procede et systeme de reactifs contenant une enzyme inactivee Withdrawn EP1504116A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE10221840 2002-05-16
DE2002121846 DE10221846A1 (de) 2002-05-16 2002-05-16 Verfahren und Reagenzsystem mit inaktiviertem Enzym
DE2002121840 DE10221840A1 (de) 2002-05-16 2002-05-16 Verfahren zur Herstellung von Polymerschichten
DE10221845 2002-05-16
DE2002121845 DE10221845A1 (de) 2002-05-16 2002-05-16 Verfahren und Reagenzsystem mit nicht-regenerierbarem Enzym-Coenzym-Komplex
DE10221846 2002-05-16
PCT/EP2003/005177 WO2003097863A1 (fr) 2002-05-16 2003-05-16 Procédé et système de réactifs contenant une enzyme inactivée

Publications (1)

Publication Number Publication Date
EP1504116A1 true EP1504116A1 (fr) 2005-02-09

Family

ID=29553736

Family Applications (3)

Application Number Title Priority Date Filing Date
EP03752757A Withdrawn EP1504116A1 (fr) 2002-05-16 2003-05-16 Procede et systeme de reactifs contenant une enzyme inactivee
EP03730061A Expired - Lifetime EP1504113B1 (fr) 2002-05-16 2003-05-16 Procede de fabrication de couches polymeres
EP03732396A Withdrawn EP1504115A1 (fr) 2002-05-16 2003-05-16 Procede et systeme de reactifs contenant un complexe enzyme-coenzyme non regenerable

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP03730061A Expired - Lifetime EP1504113B1 (fr) 2002-05-16 2003-05-16 Procede de fabrication de couches polymeres
EP03732396A Withdrawn EP1504115A1 (fr) 2002-05-16 2003-05-16 Procede et systeme de reactifs contenant un complexe enzyme-coenzyme non regenerable

Country Status (15)

Country Link
US (3) US7341830B2 (fr)
EP (3) EP1504116A1 (fr)
JP (4) JP5118288B2 (fr)
KR (2) KR101164048B1 (fr)
CN (2) CN1653189B (fr)
AT (1) ATE345396T1 (fr)
AU (3) AU2003232790A1 (fr)
BR (2) BR0311175A (fr)
CA (2) CA2493918C (fr)
DE (1) DE50305687D1 (fr)
DK (1) DK1504113T3 (fr)
ES (1) ES2275095T3 (fr)
HK (2) HK1081599A1 (fr)
MX (2) MXPA04011220A (fr)
WO (3) WO2003097859A2 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101164048B1 (ko) * 2002-05-16 2012-07-18 에프. 호프만-라 로슈 아게 비-재생성 효소-보조효소 복합체를 포함하는 방법 및 시약시스템
DE10325699B3 (de) * 2003-06-06 2005-02-10 Roche Diagnostics Gmbh System zur Analyse einer zu untersuchenden Probe und Verwendung eines solchen Systems
DE102004007983A1 (de) * 2004-02-18 2005-09-08 Roche Diagnostics Gmbh Testelement mit Einschicht-Reaktionsfilm
DE102004051830B4 (de) * 2004-10-25 2007-12-13 Roche Diagnostics Gmbh Multifunktionales Referenzsystem bei Analytbestimmungen durch Fluoreszenz
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
DE102005035461A1 (de) 2005-07-28 2007-02-15 Roche Diagnostics Gmbh Stabile NAD/NADH-Derivate
WO2007041355A2 (fr) 2005-09-30 2007-04-12 Intuity Medical, Inc. Agents catalytiques pour extraire un échantillon de liquide biologique
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
CA2564666A1 (fr) * 2005-10-25 2007-04-25 F. Hoffmann-La Roche Ag Spectroscopie de fluorescence dans un milieu absorbant
GB0526051D0 (en) * 2005-12-21 2006-02-01 Oxford Biosensors Ltd Cholesterol sensor
EP1830177A1 (fr) 2006-03-02 2007-09-05 F. Hoffman-la Roche AG Elément d'essai intégré
WO2007147086A2 (fr) * 2006-06-14 2007-12-21 Brigham Young University Copolymère acrylique résistant à l'adsorption pour des dispositifs fluidiques
EP2022859A1 (fr) * 2007-08-01 2009-02-11 Roche Diagnostics GmbH Procédé et dispositif destinés à la détermination de la concentration d'un analyte par mesure de la fluorescence
EP2093284A1 (fr) 2008-02-19 2009-08-26 F.Hoffmann-La Roche Ag Stabilisation de déhydrogénases à l'aide de coenzymes stables
WO2009145920A1 (fr) 2008-05-30 2009-12-03 Intuity Medical, Inc. Dispositif de prélèvement de liquide organique et interface de site de prélèvement
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
CA2726071C (fr) 2008-06-06 2024-01-02 Intuity Medical, Inc. Appareil de mesure de glycemie
BRPI0915491A2 (pt) 2008-07-11 2016-09-06 Universal Biosensors Pty Ltd sensor de imunoensaio
EP2398909B1 (fr) 2009-02-19 2015-07-22 F. Hoffmann-La Roche AG Cinétique réactionnelle rapide d'enzymes présentant une activité inférieure dans des couches chimiques sèches
WO2010094427A2 (fr) 2009-02-19 2010-08-26 Roche Diagnostics Gmbh Stockage peu encombrant de moyens d'analyse
EP2226008A1 (fr) 2009-02-19 2010-09-08 Roche Diagnostics GmbH Procédé de fabrication d'un chargeur analytique
EP2226007A1 (fr) 2009-02-19 2010-09-08 Roche Diagnostics GmbH Chargeur d'éléments de test doté de champs de test recouverts
EP2292751A1 (fr) 2009-08-20 2011-03-09 Roche Diagnostics GmbH Stabilisation d'enzymes à l'aide de coenzymes stables
WO2011065981A1 (fr) 2009-11-30 2011-06-03 Intuity Medical, Inc. Dispositif et procédé de fourniture de matériau d'étalonnage
EP2362207A1 (fr) * 2010-01-28 2011-08-31 F. Hoffmann-La Roche AG Système de mesure et procédé, en particulier pour déterminer le sucre dans le sang
CN103458786B (zh) 2011-04-12 2015-08-19 霍夫曼-拉罗奇有限公司 分析辅件
US9752990B2 (en) 2013-09-30 2017-09-05 Honeywell International Inc. Low-powered system for driving a fuel control mechanism
WO2013020103A1 (fr) 2011-08-03 2013-02-07 Intuity Medical, Inc. Dispositifs et procédés pour le prélèvement et l'analyse de liquides organiques
EP2620507A1 (fr) 2012-01-25 2013-07-31 Roche Diagnostics GmbH Procédé pour l'évaluation de la qualité d'un élément de test
EP2839267B1 (fr) 2012-04-19 2019-12-04 F.Hoffmann-La Roche Ag Procédé et dispositif de détermination d'une concentration d'analyte dans le sang
DE102013104906B4 (de) * 2013-05-13 2015-06-25 Brandenburgische Technische Universität Cottbus-Senftenberg Wasserfreie Immobilisierung von Enzymen
CN105247069A (zh) 2013-06-04 2016-01-13 豪夫迈·罗氏有限公司 用于fret的新化合物及与其相关的方法
US20170233787A1 (en) * 2014-08-05 2017-08-17 Becton, Dickinson And Company Methods and compositions for analyzing glucose-6-phosphate dehydrogenase activity in blood samples
KR102273051B1 (ko) 2014-10-21 2021-07-06 삼성디스플레이 주식회사 정공 수송용 재료 및 이를 이용한 유기 발광 소자
EP3339431A1 (fr) 2016-12-22 2018-06-27 Roche Diabetes Care GmbH Variantes de glucose déshydrogénase à propriétés améliorées
EP3856139A1 (fr) * 2018-09-24 2021-08-04 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Couches faites sur mesure à partir de dispersions de cellulose pour la détection d'analytes
US11579093B2 (en) * 2020-04-22 2023-02-14 SciLogica Corp. Optical component

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE638336A (fr) * 1964-12-21 1964-02-03
CS164231B2 (fr) * 1972-09-28 1975-11-07
IL57570A (en) * 1978-06-22 1982-07-30 Miles Lab Method and reagent for specific binding assay with a prosthetic group as a label component
US4238565A (en) 1978-06-22 1980-12-09 Miles Laboratories, Inc. Specific binding assay with a prosthetic group as a label component
AT367796B (de) * 1979-10-29 1982-07-26 List Hans Verfahren zur bestimmung einer stoffkonzentration in einer loesung
US4451568A (en) * 1981-07-13 1984-05-29 Battelle Memorial Institute Composition for binding bioactive substances
DE3332144A1 (de) * 1982-09-06 1984-03-08 Konishiroku Photo Industry Co., Ltd., Tokyo Analytisches element
EP0145347B1 (fr) * 1983-12-06 1989-04-19 Imperial Chemical Industries Plc Film pour photoréserve à sec
US4820399A (en) * 1984-08-31 1989-04-11 Shimadzu Corporation Enzyme electrodes
GB8608435D0 (en) * 1986-04-07 1986-05-14 Cranfield Inst Of Tech Specific binding assays
JPH0710896B2 (ja) 1987-04-30 1995-02-08 第一工業製薬株式会社 高分子量カチオン性アクリル系重合体の製造方法
GB8718430D0 (en) * 1987-08-04 1987-09-09 Ici Plc Sensor
CA1322324C (fr) * 1988-02-10 1993-09-21 Joel M. Blatt Analyses en autonomie a resolution accrue utilisant des soustractions stoechiometriques
US5340722A (en) * 1988-08-24 1994-08-23 Avl Medical Instruments Ag Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method
US5296305A (en) 1990-05-11 1994-03-22 Esslior International (Compagnie Generale D'optique) Method of fabricating a lens made of transparent polymer with modulated refracting index
GB9022304D0 (en) * 1990-10-15 1990-11-28 Ares Serono Res & Dev Ltd Assay technique
JP2977265B2 (ja) * 1990-11-19 1999-11-15 旭化成工業株式会社 感光性エラストマー構成体
DE4118880C2 (de) 1991-06-08 1998-12-17 Fraunhofer Ges Forschung Verfahren zur selektiven Bestimmung der Konzentration gelöster Substanzen in enzymatischen Reaktionen
JPH06506019A (ja) * 1991-12-18 1994-07-07 シメッド　ライフ　システムズ　インコーポレイテッド 潤滑性ポリマーネットワーク
EP0562372B1 (fr) * 1992-03-23 1997-11-26 Siemens Aktiengesellschaft Biocapteur
JPH07115998A (ja) 1993-08-31 1995-05-09 Iatron Lab Inc Ｇｏｔ測定用試薬
JPH07115997A (ja) 1993-08-31 1995-05-09 Iatron Lab Inc Ｇｐｔ測定用試薬
US5447847A (en) 1993-09-02 1995-09-05 Nissui Pharmaceutical Co., Ltd. Quantitative determination of pyruvic acid and quantitative analysis for component of living body making use of such determination
GB9404805D0 (en) * 1994-03-11 1994-04-27 Minnesota Mining & Mfg Novel developing agents for (photo)thermographic systems
JP2986712B2 (ja) * 1995-05-01 1999-12-06 キヤノン株式会社 化学センサ、それを用いた塩化物イオン濃度の測定装置及び測定方法
US5691205A (en) 1994-06-23 1997-11-25 Canon Kabushiki Kaisha Fluorometric analysis of chloride ion and chemical sensor therefor
DE4424179C2 (de) * 1994-07-08 1998-09-10 Biotechnolog Forschung Gmbh UV-polymerisierbare Enzympaste zur Herstellung von Dickschicht-Biosensoren und damit hergestellte Dickschicht-Biosensoren
JPH09248200A (ja) 1996-03-13 1997-09-22 Nissho Corp グルコース測定用試薬
US5863650A (en) * 1997-05-05 1999-01-26 Bioengineered Materials, Inc. Interfacial coatings
JP2000035413A (ja) 1998-07-16 2000-02-02 Sapporo Imuno Diagnostic Laboratory:Kk 脱水素酵素と補酵素を用いたバイオセンサ
AT409307B (de) 1999-01-12 2002-07-25 Hoffmann La Roche Optisch-chemischer sensor
JP3869601B2 (ja) 1999-11-26 2007-01-17 株式会社トクヤマ ホモシステインの測定方法
US6635412B2 (en) * 2000-07-11 2003-10-21 Martin A. Afromowitz Method for fabricating 3-D structures with smoothly-varying topographic features in photo-sensitized epoxy resists
WO2002052045A1 (fr) * 2000-12-26 2002-07-04 Aviva Biosciences Plate-formes actives et biocompatibles preparees par polymerisation de films de revetement de surface
US20030087178A1 (en) * 2001-04-20 2003-05-08 Adrian Lungu Photopolymerizable element for use as a flexographic printing plate and a process for preparing the plate from the element
KR101164048B1 (ko) * 2002-05-16 2012-07-18 에프. 호프만-라 로슈 아게 비-재생성 효소-보조효소 복합체를 포함하는 방법 및 시약시스템
JP4786451B2 (ja) 2005-07-28 2011-10-05 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Ｎａｄ／ｎａｄｈの安定化
EP1964927A1 (fr) 2007-02-27 2008-09-03 F. Hoffmann-La Roche AG Quinone en tant que médiateurs pour tests photométriques
US20080219806A1 (en) 2007-03-05 2008-09-11 Van Der Meulen Peter Semiconductor manufacturing process modules
EP2022859A1 (fr) 2007-08-01 2009-02-11 Roche Diagnostics GmbH Procédé et dispositif destinés à la détermination de la concentration d'un analyte par mesure de la fluorescence

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03097863A1 *

Also Published As

Publication number Publication date
JP5118288B2 (ja) 2013-01-16
DE50305687D1 (de) 2006-12-28
HK1081599A1 (en) 2006-05-19
WO2003097859A3 (fr) 2004-02-26
ATE345396T1 (de) 2006-12-15
MXPA04011220A (es) 2005-02-14
AU2003240666B2 (en) 2009-04-23
AU2003232790A1 (en) 2003-12-02
BR0311175A (pt) 2005-03-15
US20080182324A1 (en) 2008-07-31
KR101164048B1 (ko) 2012-07-18
JP2005528897A (ja) 2005-09-29
AU2003240666A1 (en) 2003-12-02
KR20040106531A (ko) 2004-12-17
KR20040106530A (ko) 2004-12-17
EP1504115A1 (fr) 2005-02-09
HK1081600A1 (en) 2006-05-19
JP2005528896A (ja) 2005-09-29
WO2003097863A1 (fr) 2003-11-27
EP1504113B1 (fr) 2006-11-15
ES2275095T3 (es) 2007-06-01
CA2486950C (fr) 2013-07-30
MXPA04011103A (es) 2005-02-14
BR0309947A (pt) 2005-03-01
CN100439513C (zh) 2008-12-03
CA2493918C (fr) 2012-08-28
JP4656938B2 (ja) 2011-03-23
CN1653190A (zh) 2005-08-10
JP2009275233A (ja) 2009-11-26
DK1504113T3 (da) 2007-03-05
JP2005532796A (ja) 2005-11-04
CA2493918A1 (fr) 2003-11-27
CN1653189B (zh) 2010-12-15
BR0309947B1 (pt) 2013-11-26
WO2003097864A1 (fr) 2003-11-27
US8846132B2 (en) 2014-09-30
EP1504113A2 (fr) 2005-02-09
KR101002194B1 (ko) 2011-01-13
AU2003240260B2 (en) 2008-05-22
US7951581B2 (en) 2011-05-31
CA2486950A1 (fr) 2003-11-27
AU2003240260A1 (en) 2003-12-02
US7341830B2 (en) 2008-03-11
US20050214891A1 (en) 2005-09-29
US20060099327A1 (en) 2006-05-11
CN1653189A (zh) 2005-08-10
WO2003097859A2 (fr) 2003-11-27

Similar Documents

Publication Publication Date Title
EP1504116A1 (fr) Procede et systeme de reactifs contenant une enzyme inactivee
US7189341B2 (en) Electrochemical sensor ink compositions, electrodes, and uses thereof
Campanella et al. New biosensor for superoxide radical used to evidence molecules of biomedical and pharmaceutical interest having radical scavenging properties
EP1780288B1 (fr) Spectroscopie de fluorescence dans des milieux absorbants
WO2013072275A1 (fr) Instrument d'analyse pour le dépistage d'au moins un analyte dans un échantillon
Moore et al. Enzymically amplified voltammetric sensor for microliter sample volumes of salicylate
EP2513648B1 (fr) Détection de la décomposition d'enzymes dans un élément de test par libération contrôlée d'analyte protégé
CN109520979B (zh) 一种血清中胆固醇的检测方法
JP4082505B2 (ja) アルコール分析方法
AT390803B (de) Verfahren zur bestimmung der konzentration eines enzymsubstrates und sensor zur durchfuehrung des verfahrens
Vaidya et al. Use of charged membranes to control interference by body chemicals in a glucose biosensor
DE10221845A1 (de) Verfahren und Reagenzsystem mit nicht-regenerierbarem Enzym-Coenzym-Komplex
DE10221846A1 (de) Verfahren und Reagenzsystem mit inaktiviertem Enzym
JPH11253193A (ja) クレアチンキナーゼ活性測定用試験片
EP1445603A1 (fr) Détérmination fluorométrique d'analytes avec des Amines-N-Oxides comme Indicateurs Redox
CA2473069A1 (fr) Membrane de diffusion moulable pour des applications de detection base sur un enzyme
EP1502957B1 (fr) Membrane de diffusion à couler pour des capteur basés sur un enzyme
JP3186911B2 (ja) 微量成分の定量方法
JP2010233545A (ja) ポリオールの測定方法
DD228827A1 (de) Verfahren zur bestimmung von substraten von cofaktorabhaengigen dehydrogenasen
JPH03151898A (ja) 固定化酵素利用フローインジェクション測定法
DE10221840A1 (de) Verfahren zur Herstellung von Polymerschichten

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041027

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100607

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KNAPPE, WOLFGANG-REINHOLD

Inventor name: HOENES, JOACHIM

Inventor name: HORN, CARINA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111011